key: cord-0880964-cx7mun6o
authors: Yadav, Ankush
title: Identification and Targeting Putative G-Quadruplex Sequences in Candida glabrata: A Route to Virulence and Pathogenesis Control?
date: 2021-08-08
journal: bioRxiv
DOI: 10.1101/2021.08.06.455387
sha: f950d050f1c1c9f197b23d72887f5172f2561517
doc_id: 880964
cord_uid: cx7mun6o

An increase in the number of Candida species that are resistant to antifungal medication and increases worldwide. Even individuals that are never exposed to antibiotics showing resistance to antifungal drugs. The increase in resistant candida species strains requires a search for novel targets for new antifungal agents. Preventing infection caused by candida species is a tremendous challenge in medicine. Although availability and use of antifungal drugs, disseminated candidiasis leads to a high mortality rate of about 40-60%, poor diagnosis, and improper disease management. Interest in G-quadruplexes as a therapeutic target has been increased in recent years, following the implication of this non-canonical G-quadruplex secondary structure in pathological diseases. However, G-quadruplex has been reported in many pathogens contributing to virulence and pathogenesis, including bacterial pathogens such as Staphylcoccus aureus and Enterococcus spp. Etc, viruses such as SARS-CoV2, HIV, HPV etc., and Fungi such as Candida species, Aspergillus fumigatus, etc. The present aim of the study is to identify and targeting G-Quadruplex forming sequences present in the Candida glabrata. PQSFinder (R Package) identified more than 5000 putative G-quadruplex forming sequences. Out of these, we have used PQS present in the SDH1 gene of Candida glabrata. It may be a key target to ameliorate the C.glabrata infection because it encodes a protein that plays a vital role in energy production in C.glabrata cells shown in the figure. The structure was built based on the already current structure that is telomeric G4 AGGG (TTAGGG)3 {PDB ID-4G0F} for identifying its stabilization by Gold carbine derivatives. Molecular docking and ADMET analysis show that Compound A has the highest binding affinity and has the best ADMET properties among the two compounds. The present study represents PQS in the SDH1 gene could be a novel antifungal target.

For causing infection, candida must evade host defenses and multiply in the host. The Candida species must propagate to other tissues and organs in systematic infection. Gastrointestinal and skin barrier disruption can lead to deep organ candidiasis. Candida albicans are responsible for about 50% of candidiasis and, non-albicans Candida species are responsible for the rest of the Candida infection.

Nowadays, these non-albicans Candida species such as Candida glabrata are of great concern and emerging as opportunistic pathogens. Candida glabrata has been classified as a non-pathogenic saprophyte of normal microbial flora present in healthy individuals and rarely causes fungal infections in humans [Haley, 1961] . C. glabrata is the second most organism that cause candidiasis after Candida albicans. C. glabrata do not showing dimorphic characteristics. Instead, it is found as blastoconidia in commensal microbial flora or during pathogenesis. C. glabrata was identified as Cryptococcus glabratus, and this name was first changed to Torulopsis glabrata in 1894 and then again renamed C. glabrata. The present taxonomy for C. glabrata would be Kingdom-Fungi; [Dujon et al., 2004] . It is assumed that Candida glabrata contains 5293 ORFs, out of which only 4.5% ORFs that is 238, are verified by experiments that code for the proteins. The Length of the chromosomes also varies from 4, 91,328 to 14, 55,689 bp, and chromosome A is the smallest in size, whereas chromosome M is the highest.

Preventing infection caused by candida species is a tremendous challenge in medicine. Although availability and use of antifungal drugs, disseminated candidiasis leads to a high mortality rate of about 40-60%, poor diagnosis, and improper disease management.

An increase in the number of Candida species that are resistant to antifungal medication and increases worldwide. Even individuals that are never exposed to antibiotics showing resistance to antifungal drugs. Candida species strains resistant to antifungals (such as echinocandins and fluconazole) are increasingly being identified. Their presence usually correlates with high echinocandin and azoles background usage in hospitals or intensive care units [Arendrup & Perlin, 2014 , Pfaller et al., 2011 . Candida species can form a drug-resistant biofilm that is a vital factor for pathogenesis in humans. The majority of sessile cells [Ramage et al., 2012] and biofilms [Kuhn & Ghannoum, 2004] within candida species are less susceptible to antifungal medications than the planktonic cells. The increase in resistant candida species strains requires a search for novel targets for new antifungal agents.

G-quadruplexes forming sequences are conserved (evolutionary) drug targets. They are found in the essential regions of the genome of prokaryotes, eukaryotes, and viruses (Murat & Balasubramanian, 2014) . G-quadruplexes are secondary structures formed in nucleic acid by the association of Guanines in G-rich sequences to form G-tetrad structures. G-quadruplex is enriched in the regulatory regions, especially the telomeric and promoter regions of prokaryotic and eukaryotic genomes (Varshney et al., 2020) . Studies have indicated that G-quadruplexes also formed on the DNAs and RNAs template strands (Endoh et al., 2013) . Interest in G-quadruplexes as a therapeutic target has been increased in recent years, following the implication of this noncanonical G-quadruplex secondary structure in pathological diseases such as cancer (Balasubramanian et al., 2011) . However, now G-quadruplex has been reported in the vast number of pathogens contributing to virulence and pathogenesis including bacterial pathogens such as All predicted PGQ sequences were recorded, and their location was elucidated using the Graphics mode of the GenBank database (http://www.ncbi.nlm.nih.gov/gene/).

2.2 Prediction of Secondary confirmation of SDH1 PQS and SDH1 G4 Structure:

The hairpin conformation of SDH1 PQS was determined using an RNAfold web server. The entropy of each nucleotide that participated in the formation of hairpin conformation was elucidated by the RNAfold web server. The Structure of SDH1 G4 was not explained yet. Therefore the predicted model of SDH1 G4 was built based on the already present structure that is telomeric G4 AGGG (TTAGGG)3 {PDB ID-4G0F}. This sequence was selected because of its sequence similarity with the SDH1 G4 sequence. As represented in Table1, The 4G0F DNA sequence was modified to attain the nucleotide sequence of SDH1 G4 CGGG(CUCGGG)3 using the Discovery studio mutation tool. Adenine in position one was mutated to cytosine. The thymine residue in positions 5, 11, and 17 was mutated to cytosine, whereas thymine in positions 6,12, and 18 was mutated to uracil. Adenine in positions 7, 13, and 19 were also mutated to cytosine. The mutation was carried out in the loop residues, so that integrity of the G-tetrads was not compromised. The 2' position of each ribose was modified from 2'-OH (oxy) to 2'-H (deoxy) in order to convert the nucleotide sequence into an RNA nucleotide. The predicted model was further optimized by molecular dynamics simulation 2.3 Structure Designing and NMR Studies of bis(1,3,7-trimethyl-2,6-dioxo-2,3,6,7,8,9hexahydro-1H-purin-8-yl)gold (Compound A), bis (1,3,7,9-tetramethyl-2,6-dioxo-2,3,6,7,8,9- hexahydro-1H-purin-8-yl)gold (Compound B) and bis (3,7,9-trimethyl-2,6-dioxo-2,3,6,7,8,9- hexahydro-1H-purin-8-yl)gold (Compound C):

The structure of Compound A, B, and C was designed using MarvinSketch Software based on the following parameter: Modification can occur at the N9 position of the Xanthine derivative conjugated with Gold in the scaffold causes loss of G-quadruplex binding selectivity and potency.

Modification occurs at the N1 position of Xanthine derivative conjugated with Gold in the scaffold can retain the planer geometry of the designed structure (Meier-Menches et al., 2020) . 1 H and 13 C NMR spectra of compounds A, B, and C were determined using an NMR prediction plugin with MarvinSketch Tool. The NMR spectra of compounds A, B, and C were recorded in DMSO-d6

[deuterated dimethyl sulfoxide]. The tetramethylsilane was used as the reference sample, and the frequency was adjusted at 500 MHz.

The proposed 3D model of the SDH1 G-quadruplex structure was used as a molecular target for docking studies. Both the proposed SDH1 G-quadruplex structure and ligands were prepared using the Autodock tool [Morris et al., 2009] . After computing the Gasteiger charges and polar hydrogen bonds, docking studies were done with the AutoDock4.2 program using the Lamarckian genetic algorithm [Morris et al., 2009 ]. The Grid box size was constrained to (100 ×100 ×100) A o along the axes (x,y, z), with a grid spacing of 0.375 A o . For ligands, 25 GA runs were performed with a population size of 150 random individuals. For each ligand, the maximum number of the evaluation is set to 2.5×10 7 . The rate of gene mutation and cross-over is set to 0.02 and 0.8, respectively. In docking simulation, ligands were allowed full flexibility, whereas the SDH1 Gquadruplex structure was not fully flexible and kept rigid. The best conformers were chosen based on the binding free energy.

Pharmacokinetics properties like absorption, distribution, metabolism, excretion, and toxicity parameters of compounds A, B, and C were analyzed using the pkCSM webserver. The pkCSM webserver determined ADMET profiling based on the ADMET descriptor algorithm (Pires et al., 2015) . ADMET profiling allows understanding the drug candidate's safety and efficiency and deciphers the viability of the drug [Guan et al., 2019] . This ADMET study includes drug-like properties, lipophilicity, pKa, the volume of distribution, absorption, transporter, solubility, metabolism, hepatic clearance, etc. The absorption of the compounds correlates with the factor, including permeability through the membrane (specify by Caco-2 cell line), P-glycoprotein substrate, or inhibitor. The absorption also depends on the skin permeability and absorption through the intestine. The distribution of the compound (Drug to be molecule) correlates with the factors such as blood-Brain-Barrier, permeability through CNS. The distribution also depends on the volume of the distribution of the drug molecule. Metabolism of the drug molecule depends on the CYP substrate and inhibitor models such as CYP3A4, CYP2C19, CYP2D6, CYP2D6, the total clearance model. In comparison, the drug's toxicity is determined based on the hERG inhibition, AMES toxicity, and hepatotoxicity.

3.1 Putative G-quadruplex forming sequences in Candida glabrata genome:

Presently, there are less effective antifungal agents available to treat fungal infections caused by Considering the likeness between two sequences may correlate with similar functions. For conquering multidrug-resistant fungal infection, evolutionary conservation is essential that satisfy one of the vital criteria to work as a promising drug target. Therefore we utilized the BLAST and GO annotation to determine the probability of each cluster in Candida glabrata.

The secondary structure of the G-quadruplex forming sequence in the SDH1 gene of Candida glabrata was predicted using the RNAfold web server shown in figure 1, and its stability was found to be G o : -19.6 Kcal/mol. The entropy vs. position graph (figure 1) shows that the trinucleotide (CUC) loop has more entropy, whereas G-tetrad's forming guanine nucleotide have less entropy. Figure 10 Depicts the hairpin conformation of SDH1 PQS, and the graph represents each nucleotide's positional entropy. Since the structure of SDH1 G-quadruplex is not modeled, so we obtained a predicted model on the basis of parallel G4 that is telomeric G4

loops. G2-G8-G14-G20 guanine nucleotides were interconnected by hoogsteen base-pairing where N7, O6 of G2 formed hydrogen bonds with N2 and N1 of G20 nucleotide, N7, O6 of G20 formed hydrogen bond with N1 and N2 of G14, whereas N7, O6 of G20 formed hydrogen bond with N1 and N2 of G8. All these G2-G8-G14-G20 together formed G-tetrad and stabilized by K + ion where K + formed a bond with O6 of all G's of the tetrad, which help stabilize the G-tetrad. 4,17) ).

In-silico ADMET study was used to depict various pharmacokinetic parameters shown in table 2.

It is suggested as an initial step to analyse chemical compound entity (novel drug) to prevent resources and time on the lead compound that the human body may metabolize in an inactive form or maybe cause toxicity and unable to penetrate the membrane. In comparison, compound C was found to be a non-substrate and non-inhibitor of P-glycoprotein.

The calculated value for Blood-Brain-Barrier permeability for compounds A, B, and C comes out low and unable to cross the BBB. The main CYPs used in metabolism were CYP1A2, CYP2C9, CYP2C19, and CYP3A4, and compounds A, B, and C were found to be non-inhibitory and nonsubstrate for CYP1A2, CYP2C9, CYP2C19, and CYP3A4. AMES Toxicity was exploited to analyze whether these compounds were mutagenic or not. It is found that compounds A, B, and C were non-mutagenic as well as non-carcinogenic. Total clearance in terms of excretion for compound A was 1.508 log ml/min/kg. Compound B has a total clearance of 1.618 log ml/min/kg, and compound C has 1.475 log ml/min/kg. The calculated oral rat toxicity (LD50) for compound A was found to be 2.357 mol/kg, LD50 for compound B comes out 2.172 mol/kg, and for compound C, it came out to be 2.007 mol/kg.

Molecular docking has been performed using AutoDock software, and the best binding pose based on the lowest free energy was chosen. The molecular interaction between SDH1 G4-compound complexes was analyzed using discovery studio software shown in table 3. Compound A was docked between the G-tetrads and C5U6C7 loop shown in figure 3 . The C7 is present in the loop, and G15 of G-tetrad forms a carbon-hydrogen bond with compound A, respectively shown in light green color, and G14 and G20 of G-tetrads binds with compound A through hydrogen bond shown in green color and. Whereas G20 also formed metal-acceptor bond with a gold atom present in the 

Determining the putative quadruplex sequences within the pathogenic or drug resistance genes of In the future, these experimental and computational should be correlated with biophysical techniques to ascertain the validity of these data.

There is no conflict of interest declared by the author 

International study of the prevalence and outcomes of infection in intensive care units

The Candida pathogenic species complex. Cold Spring Harbor Perspectives in Medicine

Candida albicans-Biology, molecular characterization, pathogenicity, and advances in diagnosis and control -An update

Invasive candidiasis and candidemia: new guidelines

Yeasts of Medical Importance

Genome evolution in yeasts

Echinocandin resistance: An emerging clinical problem? Current Opinion in Infectious Diseases

Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: Report from the SENTRY Antimicrobial Surveillance Program

Fungal Biofilm Resistance

Candida biofilms: Antifungal resistance and emerging therapeutic options

Existence and consequences of G-quadruplex structures in DNA

The regulation and functions of DNA and RNA G-quadruplexes

Suppression of gene expression by Gquadruplexes in open reading frames depends on G-quadruplex stability

Targeting G-quadruplexes in gene promoters: A novel anticancer strategy?

Analysis of putative quadruplex-forming sequences in fungal genomes: Novel antifungal targets?

Cover Feature: An Organometallic Gold(I) Bis-N-Heterocyclic Carbene Complex with

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures

ADMET-scorea comprehensive scoring function for evaluation of chemical drug-likeness

Ortholog(s) have MAP kinase activity, calmodulin binding